These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2066858)

  • 1. Intellectual outcome in children with maple syrup urine disease.
    Kaplan P; Mazur A; Field M; Berlin JA; Berry GT; Heidenreich R; Yudkoff M; Segal S
    J Pediatr; 1991 Jul; 119(1 Pt 1):46-50. PubMed ID: 2066858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual performance of children with maple syrup urine disease.
    Hilliges C; Awiszus D; Wendel U
    Eur J Pediatr; 1993 Feb; 152(2):144-7. PubMed ID: 8444223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.
    Hoffmann B; Helbling C; Schadewaldt P; Wendel U
    Pediatr Res; 2006 Jan; 59(1):17-20. PubMed ID: 16326996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.
    Couce ML; Ramos F; Bueno MA; Díaz J; Meavilla S; Bóveda MD; Fernández-Marmiesse A; García-Cazorla A
    Eur J Paediatr Neurol; 2015 Nov; 19(6):652-9. PubMed ID: 26232051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Outcomes for Maple Syrup Urine Disease Detected by Newborn Screening.
    Mengler K; Garbade SF; Gleich F; Thimm E; May P; Lindner M; Lüsebrink N; Marquardt T; Hübner V; Krämer J; Neugebauer J; Beblo S; Gillitzer C; Grünert SC; Hennermann JB; Kamrath C; Marquardt I; Näke A; Murko S; Schmidt S; Schnabel E; Lommer-Steinhoff S; Hoffmann GF; Beime J; Santer R; Kölker S; Mütze U
    Pediatrics; 2024 Aug; 154(2):. PubMed ID: 38957900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
    Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
    J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients.
    Lee JY; Chiong MA; Estrada SC; Cutiongco-De la Paz EM; Silao CL; Padilla CD
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S281-5. PubMed ID: 18989748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive profiles in MSUD school-age patients.
    Bouchereau J; Leduc-Leballeur J; Pichard S; Imbard A; Benoist JF; Abi Warde MT; Arnoux JB; Barbier V; Brassier A; Broué P; Cano A; Chabrol B; Damon G; Gay C; Guillain I; Habarou F; Lamireau D; Ottolenghi C; Paermentier L; Sabourdy F; Touati G; Ogier de Baulny H; de Lonlay P; Schiff M
    J Inherit Metab Dis; 2017 May; 40(3):377-383. PubMed ID: 28324240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.
    Simon E; Wendel U; Schadewaldt P
    Turk J Pediatr; 2005; 47(1):8-13. PubMed ID: 15884622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent maple syrup urine disease: two case reports.
    Axler O; Holmquist P
    Pediatrics; 2014 Feb; 133(2):e458-60. PubMed ID: 24394677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant maple syrup urine disease (MSUD)--the entire spectrum.
    Simon E; Flaschker N; Schadewaldt P; Langenbeck U; Wendel U
    J Inherit Metab Dis; 2006 Dec; 29(6):716-24. PubMed ID: 17063375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maple syrup urine disease: Clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the Republic of Ireland.
    O'Reilly D; Crushell E; Hughes J; Ryan S; Rogers Y; Borovickova I; Mayne P; Riordan M; Awan A; Carson K; Hunter K; Lynch B; Shahwan A; Rüfenacht V; Häberle J; Treacy EP; Monavari AA; Knerr I
    J Inherit Metab Dis; 2021 May; 44(3):639-655. PubMed ID: 33300147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maple syrup urine disease in Brazil: a panorama of the last two decades.
    Herber S; Schwartz IV; Nalin T; Oliveira Netto CB; Camelo Junior JS; Santos ML; Ribeiro EM; Schüler-Faccini L; Souza CF
    J Pediatr (Rio J); 2015; 91(3):292-8. PubMed ID: 25512172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
    Yıldız Y; Akcan Yıldız L; Dursun A; Tokatlı A; Coşkun T; Tekşam Ö; Sivri HS
    Eur J Pediatr; 2020 Jul; 179(7):1107-1114. PubMed ID: 32048023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
    Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
    Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychometric outcome predictors for adults with maple syrup urine disease.
    le Roux C; Murphy E; Hallam P; Lilburn M; Orlowska D; Lee P
    J Inherit Metab Dis; 2006 Feb; 29(1):201-2. PubMed ID: 16601892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the diagnosis and treatment of maple syrup urine disease: experience in Galicia (Spain)].
    Couce Pico ML; Castiñeiras Ramos DE; Bóveda Fontán MD; Iglesias Rodríguez AJ; Cocho de Juan JA; Fraga Bermúdez JM
    An Pediatr (Barc); 2007 Oct; 67(4):337-43. PubMed ID: 17949643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental profile of patients with maple syrup urine disease.
    Nord A; van Doorninck WJ; Greene C
    J Inherit Metab Dis; 1991; 14(6):881-9. PubMed ID: 1723442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.
    Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Li M; Qin Y; Yang Y
    Eur J Med Genet; 2015 Nov; 58(11):617-23. PubMed ID: 26453840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.